荣昌生物(688331.SH)获实控人控制企业累计增持18万股

智通财经07-16

智通财经APP讯，荣昌生物(688331.SH)发布公告，2024年7月9日至2024年7月16日，公司实际控制人王威东、房健民、林健、王荔强、王旭东、邓勇、熊晓滨、杨敏华、温庆凯、魏建良通过其控制的企业烟台荣昌控股集团有限公司通过上海证券交易所系统以集中竞价方式累计增持公司股份18万股，占公司总股本的0.0331%，合计增持金额为510.9万元(不含交易费用)，已超过本次增持计划下限金额1000...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2451961808?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-16 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2451961808","market":"hk","top_or_hot":-1,"title":"荣昌生物(688331.SH)获实控人控制企业累计增持18万股","media":"智通财经","content":"<div>\n<p>智通财经APP讯，荣昌生物(688331.SH)发布公告，2024年7月9日至2024年7月16日，公司实际控制人王威东、房健民、林健、王荔强、王旭东、邓勇、熊晓滨、杨敏华、温庆凯、魏建良通过其控制的企业烟台荣昌控股集团有限公司通过上海证券交易所系统以集中竞价方式累计增持公司股份18万股，占公司总股本的0.0331%，合计增持金额为510.9万元(不含交易费用)，已超过本次增持计划下限金额1000...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1151599.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>荣昌生物(688331.SH)获实控人控制企业累计增持18万股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n荣昌生物(688331.SH)获实控人控制企业累计增持18万股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-16 18:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1151599.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，荣昌生物(688331.SH)发布公告，2024年7月9日至2024年7月16日，公司实际控制人王威东、房健民、林健、王荔强、王旭东、邓勇、熊晓滨、杨敏华、温庆凯、魏建良通过其控制的企业烟台荣昌控股集团有限公司通过上海证券交易所系统以集中竞价方式累计增持公司股份18万股，占公司总股本的0.0331%，合计增持金额为510.9万元(不含交易费用)，已超过本次增持计划下限金额1000...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1151599.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1151599.html","article_id":"2451961808","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2451961808","pubTimestamp":1721124218,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，荣昌生物(688331.SH)发布公告，2024年7月9日至2024年7月16日，公司实际控制人王威东、房健民、林健、王荔强、王旭东、邓勇、熊晓滨、杨敏华、温庆凯、魏建良通过其控制的企业烟台荣昌控股集团有限公司通过上海证券交易所系统以集中竞价方式累计增持公司股份18万股，占公司总股本的0.0331%，合计增持金额为510.9万元(不含交易费用)，已超过本次增持计划下限金额1000万元的50%，本次增持计划尚未实施完毕。烟台荣昌控股集团有限公司将继续按照相关增持计划，在增持计划实施期限内增持公司股份。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688331":"荣昌生物","BK1161":"生物科技","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","BK1574":"生物医药B类股","09995":"荣昌生物","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","BK1583":"高瓴概念","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","BK0239":"医药制造"},"translate_title":"Rongchang Biotech (688331. SH) has acquired a cumulative increase of 180,000 shares in the company controlled by the actual controller","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688331":1,"09995":1},"content_text":"智通财经APP讯，荣昌生物(688331.SH)发布公告，2024年7月9日至2024年7月16日，公司实际控制人王威东、房健民、林健、王荔强、王旭东、邓勇、熊晓滨、杨敏华、温庆凯、魏建良通过其控制的企业烟台荣昌控股集团有限公司通过上海证券交易所系统以集中竞价方式累计增持公司股份18万股，占公司总股本的0.0331%，合计增持金额为510.9万元(不含交易费用)，已超过本次增持计划下限金额1000万元的50%，本次增持计划尚未实施完毕。烟台荣昌控股集团有限公司将继续按照相关增持计划，在增持计划实施期限内增持公司股份。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2451961808"}